Same old garbage posts and downNew 52 week low $2.56.
The analyst predicting $2.30 may see it come true next week. No reason for it to stay at these levels IMO.
No pipeline and it takes years to get drugs through trials and FDA approval. There is only about 8-10 months of cash with no revenue.